SNAP-8 (10mg)
Technische Spezifikationen
| Reinheit (HPLC) | ≥95% (HPLC) |
| CAS-Nummer | 868844-74-0 |
| Form | White lyophilized powder |
| Lagerung | -20°C |
| Sequenz | Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂ |
| Molekulargewicht | 1,075.17 g/mol |
| Salzform | Acetate |
| Löslichkeit | Soluble in water |
SNAP-8 (10mg)
EUR-Listenpreis · HU, SK, CZ, PL
- Eurozone (EUR)90,00 EUR
- Ungarn (HU)90,00 EUR≈ 36 000 Ft
- Slowakei (SK)90,00 EUR
- Tschechien (CZ)90,00 EUR≈ 2 250 Kč
- Polen (PL)90,00 EUR≈ 382,50 zł
Gleicher EUR-Listenpreis für Lieferung nach Ungarn, Slowakei, Tschechien und Polen. Abrechnung in EUR.
HUF/CZK/PLN sind indikativ aus EUR umgerechnet; die Slowakei nutzt EUR. Kurse annähernd. Abrechnung in EUR.
SNAP-8 — kosmetisches Oktapeptid, das die SNARE-Fusion an neuromuskulären Endigungen hemmt; in In-vitro- und dermatologischen Modellen. Nur RUO — ausschließlich für Laborforschung; nicht zum menschlichen Verzehr.
Ausschließlich für Laborforschung.
Nicht für den menschlichen Verzehr, tierärztliche oder diagnostische Zwecke.
From the Peptide Explorer
An octapeptide that competes with SNAP-25 for incorporation into the SNARE complex, reducing neuromuscular junction signaling. As an extended version of Argireline (Acetyl Hexapeptide-3), SNAP-8 offers enhanced competition for the SNARE complex binding site.
Key Mechanisms
- ›SNARE complex disruption
- ›SNAP-25 competitive inhibition
- ›Reduced neurotransmitter vesicle fusion
- ›Topical muscle relaxation
- ›Expression line reduction
Primary Research Areas
- ›Expression wrinkle research
- ›Topical neuromodulation
- ›SNARE complex pharmacology
Key Research Findings
- Demonstrated SNARE complex disruption in vitro neurotransmission assays
- Reduced expression wrinkle depth by up to 63% in 28-day clinical study (topical)
- Enhanced activity compared to parent compound Argireline in competitive assays
Research Overview
An octapeptide that competes with SNAP-25 for incorporation into the SNARE complex, reducing neuromuscular junction signaling. As an extended version of Argireline (Acetyl Hexapeptide-3), SNAP-8 offers enhanced competition for the SNARE complex binding site.
Origin: Extended analog of SNAP-25 competitor Argireline (Acetyl Hexapeptide-3)
Mechanism of Action
- SNARE complex disruption
- SNAP-25 competitive inhibition
- Reduced neurotransmitter vesicle fusion
- Topical muscle relaxation
- Expression line reduction
Primary Research Areas
- Expression wrinkle research
- Topical neuromodulation
- SNARE complex pharmacology
Key Published Findings
- Demonstrated SNARE complex disruption in vitro neurotransmission assays
- Reduced expression wrinkle depth by up to 63% in 28-day clinical study (topical)
- Enhanced activity compared to parent compound Argireline in competitive assays
Research Protocol
Commonly studied routes: Topical. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
Room temperature in formulation
Important Notice
SNAP-8 (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Forschungsspezifikationen
Synthesized for strict analytical consistency. Verified via HPLC/MS.Qualitätsstandards ansehen →
Handhabung & Lagerung
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water